BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17846012)

  • 1. [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy].
    Farace F; Bidart JM
    Bull Cancer; 2007 Jul; 94 Spec No():S254-9. PubMed ID: 17846012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating endothelial cells as biomarkers in clinical oncology.
    Mancuso P; Bertolini F
    Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells.
    Bertolini F
    Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease.
    Dome B; Dobos J; Tovari J; Paku S; Kovacs G; Ostoros G; Timar J
    Cytometry A; 2008 Mar; 73(3):186-93. PubMed ID: 18000872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects.
    Mariucci S; Rovati B; Bencardino K; Manzoni M; Danova M
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e40-8. PubMed ID: 20088999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
    Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
    Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifaceted circulating endothelial cell in cancer: towards marker and target identification.
    Bertolini F; Shaked Y; Mancuso P; Kerbel RS
    Nat Rev Cancer; 2006 Nov; 6(11):835-45. PubMed ID: 17036040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
    Twardowski PW; Smith-Powell L; Carroll M; VanBalgooy J; Ruel C; Frankel P; Synold TW
    Cancer Invest; 2008 Feb; 26(1):53-9. PubMed ID: 18181046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization.
    Hunting CB; Noort WA; Zwaginga JJ
    Vox Sang; 2005 Jan; 88(1):1-9. PubMed ID: 15663716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy.
    Dome B; Timar J; Ladanyi A; Paku S; Renyi-Vamos F; Klepetko W; Lang G; Dome P; Bogos K; Tovari J
    Crit Rev Oncol Hematol; 2009 Feb; 69(2):108-24. PubMed ID: 18768327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
    Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay.
    Jacques N; Vimond N; Conforti R; Griscelli F; Lecluse Y; Laplanche A; Malka D; Vielh P; Farace F
    J Immunol Methods; 2008 Sep; 337(2):132-43. PubMed ID: 18662694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
    Rabascio C; Muratori E; Mancuso P; Calleri A; Raia V; Foutz T; Cinieri S; Veronesi G; Pruneri G; Lampertico P; Iavarone M; Martinelli G; Goldhirsch A; Bertolini F
    Cancer Res; 2004 Jun; 64(12):4373-7. PubMed ID: 15205354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bone marrow constitutes a reservoir of pericyte progenitors.
    Lamagna C; Bergers G
    J Leukoc Biol; 2006 Oct; 80(4):677-81. PubMed ID: 16888086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
    Bertolini F
    Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial progenitor cells in breast cancer patients.
    Richter-Ehrenstein C; Rentzsch J; Runkel S; Schneider A; Schönfelder G
    Breast Cancer Res Treat; 2007 Dec; 106(3):343-9. PubMed ID: 17972175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications.
    Le Bourhis X; Romon R; Hondermarck H
    Breast Cancer Res Treat; 2010 Feb; 120(1):17-24. PubMed ID: 20033768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells in tumor angiogenesis.
    Fang S; Salven P
    J Mol Cell Cardiol; 2011 Feb; 50(2):290-5. PubMed ID: 21047516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cells as biomarkers of prostate cancer.
    Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
    Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A surrogate marker to monitor angiogenesis at last.
    Schneider M; Tjwa M; Carmeliet P
    Cancer Cell; 2005 Jan; 7(1):3-4. PubMed ID: 15652744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.